US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:24:32 Source：International Intrigue news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：NBA playoffs: Edwards leads Wolves to 98
- Next：Company wins court ruling to continue development of Michigan factory serving EV industry
Related articles
- Lynn Williams breaks NWSL goal
- A Supreme Court social media ruling could set new free speech standards
- Australia to open the Formula 1 season in 2025 as Bahrain and Saudi races shift for Ramadan
- Election 2024 poll: Americans dissatisfied with Biden, Trump
- Ben Whishaw lights up the Croisette as he joins his co
- Democrats Daniels and Figures stress experience ahead of next week's congressional runoff
- Heat never trail on the way to a 125
- Heat never trail on the way to a 125
- Amtrak train hits pickup truck in upstate New York, 3 dead including child
- Bryson DeChambeau, matured in both game and attitude, opens with 65 to lead the Masters
- Yu Darvish extends scoreless innings streak to 25 in Padres' 9
- Judge in Trump’s classified files case agrees to protect witness identities
- Why more state abortion bans present opportunities for Democrats
- More history for Tiger Woods. He makes the Masters cut for a record 24th time in a row
- Celebrity birthdays for the week of May 26
- Lazio booed by own fans but Anderson leads from the front in 4
- Election 2024: Latino voters are a target for misinformation
- Trump declines to endorse national abortion ban
- Who is Jacob Zuma, the former South African president disqualified from next week's election?
- Oil and gas companies must pay more to drill on federal lands under new Biden administration rule
Random recommendation